Europe

Netflix is an increasingly attractive patent litigation target

Recently targeted by Broadcom and Personalized Media Communications, the streaming giant is beginning to prepare for its new IP normal

Netflix is an increasingly attractive patent litigation target
Chinese firms turn tables in solar patent battle
28 May 2020

Chinese firms turn tables in solar patent battle

South Korea’s Hanwha Q-Cells looks to be coming up short in a big ITC case, and now a state-owned Chinese rival is going on the offensive

European Patent Office still top for quality and service, new <em>IAM</em> benchmarking report finds
27 May 2020

European Patent Office still top for quality and service, new IAM benchmarking report finds

Top ratings once again for the agency led by António Campinos, but Andrei Iancu’s USPTO slips down, according to respondents to our annual survey of in-house and private practice professionals

Latest

View all
26 May 2020

Revealed: the billions to be spent on patent renewals in 2021 and beyond

Samsung on the hook for over $135 million this year alone, with China's national IP office and the USPTO set to pull in $100 billion over lifetime of all their active grants Read more

26 May 2020

India’s growing docket of high-tech litigation on hold

Nokia, Philips and Fractus are among the patent owners with active cases targeting major Chinese companies Read more

21 May 2020

Global calls for compulsory covid-19 patent licensing build

Scrutiny of biopharma innovators’ coronavirus IP strategies will continue to intensify in coming months as concerns mount about access to treatments Read more

19 May 2020

Top 50 PCT representative firms revealed

Japan’s Shiga International Patent Office is number one on the list, with Fish & Richardson and Epping Hermann Fischer leading for the US and Europe respectively Read more

Designs

View all
26 Mar 2020

Final call to take part in this year’s IAM benchmarking survey

Help us to identify the key trends currently shaping the global IP market Read more

7 Mar 2020

Daren Tang must seize Asia’s first chance to run the global IP system

After a bruising WIPO director-general election process, Singaporean nominee’s first priority should be to build bridges between the US and China Read more

6 Mar 2020

Notice of postponement - IPBC Europe 2020 and IP Risk Management Europe 2020

New dates for both events, which had been scheduled to take place in the last week of March, will be announced as soon as possible Read more

18 Feb 2020

Tell us what you think of the latest developments in the global IP market

IAM's annual IP benchmarking survey opens today Read more

Finance

View all
6 May 2020

UK parliament committee warned on China’s plans for Imagination Technologies

Imagination owner explains that licensing IP is not the same as transferring it, but freshly resigned CEO claims that only diligent management oversight can prevent key trade secret loss Read more

15 Apr 2020

Looking for IP value in a time of economic shock

Patents, know-how and data, as well as other intellectual assets, are all very interesting opportunities right now - if you know what you are doing Read more

7 Apr 2020

Chinese investors spark IP fears with plans for British chip firm

UK government called on to investigate as Chinese backer moves to take up board seats, but the time to worry about IP ownership may be past Read more

26 Mar 2020

Final call to take part in this year’s IAM benchmarking survey

Help us to identify the key trends currently shaping the global IP market Read more

Frand/SEPS

View all
11 May 2020

Sisvel wins closely watched German FRAND case

A Supreme Court decision issued last week in favour of the licensing firm could make patent hold-out a far less attractive option Read more

30 Apr 2020

SEP holders are under no obligation to license to all under EU law

Why FRAND commitments do not mean that patent owners must do deals with everyone in the production chain Read more

28 Apr 2020

Sources: Key Unwired Planet v Huawei SEP case has not settled

Contrary to reports circulating yesterday, parties have not reached an agreement and are waiting on the UK Supreme Court’s much-anticipated ruling Read more

27 Apr 2020

Despite reported Unwired Planet/Huawei settlement, the UK Supreme Court could still issue much-anticipated decision

Were the judgment not to be handed down, the FRAND injunction principles previously established in the lower courts would be confirmed - a big win for SEP owners Read more

Law & Policy

View all
19 May 2020

EPO plant patent change after president’s intervention raises major concerns

The enlarged board’s decision that plants produced by biological processes are unpatentable has shocked the IP profession and came after office head António Campinos asked it to look again at previous ruling Read more

12 May 2020

We need answers on AI and inventorship - and soon, says DABUS pioneer

Rejected at the UKIPO, the EPO and now the USPTO, the two patent applications highlight how laws are lagging reality and potentially harming the innovation process as lines between human and machine powered inventions blur Read more

12 May 2020

Six key takeaways from the CJEU’s latest SPC ruling

Royalty Pharma decision answers important questions about Article 3(a) of the EU’s patent extension rights regulation, but creates new uncertainties Read more

11 May 2020

Sisvel wins closely watched German FRAND case

A Supreme Court decision issued last week in favour of the licensing firm could make patent hold-out a far less attractive option Read more

Litigation

View all
19 May 2020

EPO plant patent change after president’s intervention raises major concerns

The enlarged board’s decision that plants produced by biological processes are unpatentable has shocked the IP profession and came after office head António Campinos asked it to look again at previous ruling Read more

18 May 2020

PGR decision provides much-needed clarity in fast-growing microbiome space

First post-grant decision in the technology sector nevertheless gives some hope to gut bacteria innovators, despite invalidating a key cancer treatment patent Read more

15 May 2020

Five key takeaways from Akebia v Fibrogen

UK High Court judgment highlights vulnerability of broad Markush claims Read more

12 May 2020

Six key takeaways from the CJEU’s latest SPC ruling

Royalty Pharma decision answers important questions about Article 3(a) of the EU’s patent extension rights regulation, but creates new uncertainties Read more

Market Developments

View all
18 May 2020

PGR decision provides much-needed clarity in fast-growing microbiome space

First post-grant decision in the technology sector nevertheless gives some hope to gut bacteria innovators, despite invalidating a key cancer treatment patent Read more

14 May 2020

Patent cliff fears drive through 2020’s second largest pharma deal

Despite an M&A slowdown amid coronavirus uncertainties, Alexion Pharmaceuticals has splashed out more than $1 billion in the face of imminent threats to its IP position in the US and Europe Read more

2 May 2020

It’s a downturn Jim, but not as IP owners know it

Patent rights may fare well in a recession but this is a global market unlike any other we have seen before Read more

30 Apr 2020

IP is crucial to finding breakthrough covid-19 medicines, Novartis policy head states

“We are only in the position to tackle the pandemic, because of where the system has brought us so far,” says Corey Salsberg in an exclusive interview with IAM Read more

Non-Practising Entities

View all
11 May 2020

Sisvel wins closely watched German FRAND case

A Supreme Court decision issued last week in favour of the licensing firm could make patent hold-out a far less attractive option Read more

2 May 2020

It’s a downturn Jim, but not as IP owners know it

Patent rights may fare well in a recession but this is a global market unlike any other we have seen before Read more

29 Apr 2020

Big OLED patent deal signifies strategy shift at Konica Minolta

The Japanese company has announced a major transaction with Merck, about one year after inaugurating a new IP strategy department Read more

28 Apr 2020

Sources: Key Unwired Planet v Huawei SEP case has not settled

Contrary to reports circulating yesterday, parties have not reached an agreement and are waiting on the UK Supreme Court’s much-anticipated ruling Read more

Patent Pools

View all
30 Apr 2020

IP is crucial to finding breakthrough covid-19 medicines, Novartis policy head states

“We are only in the position to tackle the pandemic, because of where the system has brought us so far,” says Corey Salsberg in an exclusive interview with IAM Read more

27 Apr 2020

Tesla targeted again - this time by Conversant

West Texas complaints follow Sharp lawsuit in Japan as friction between auto OEMs and SEP owners continues to build Read more

16 Apr 2020

Exclusive: New IP policy to help forge partnerships on potential UK covid-19 vaccine

Licensing deals on crucial technologies expected in next two months, says Oxford University tech transfer chief, after scientist indicates significant progress in efforts to find coronavirus treatment Read more

9 Apr 2020

World leaders hatch further plans for accessibility of covid-19 IP rights

WHO to establish voluntary patent pool, while Greek Prime Minister calls for EU to buy rights to vaccines and tests Read more

Patents Law

View all
19 May 2020

EPO plant patent change after president’s intervention raises major concerns

The enlarged board’s decision that plants produced by biological processes are unpatentable has shocked the IP profession and came after office head António Campinos asked it to look again at previous ruling Read more

18 May 2020

PGR decision provides much-needed clarity in fast-growing microbiome space

First post-grant decision in the technology sector nevertheless gives some hope to gut bacteria innovators, despite invalidating a key cancer treatment patent Read more

15 May 2020

Hoffmann Eitle named top EPO filer for 2019

German and UK firms dominate the list of firms filing most published patent applications for clients at the agency last year Read more

15 May 2020

Five key takeaways from Akebia v Fibrogen

UK High Court judgment highlights vulnerability of broad Markush claims Read more

Strategy

View all
15 May 2020

Five key takeaways from Akebia v Fibrogen

UK High Court judgment highlights vulnerability of broad Markush claims Read more

14 May 2020

Patent cliff fears drive through 2020’s second largest pharma deal

Despite an M&A slowdown amid coronavirus uncertainties, Alexion Pharmaceuticals has splashed out more than $1 billion in the face of imminent threats to its IP position in the US and Europe Read more

12 May 2020

We need answers on AI and inventorship - and soon, says DABUS pioneer

Rejected at the UKIPO, the EPO and now the USPTO, the two patent applications highlight how laws are lagging reality and potentially harming the innovation process as lines between human and machine powered inventions blur Read more

11 May 2020

Sisvel wins closely watched German FRAND case

A Supreme Court decision issued last week in favour of the licensing firm could make patent hold-out a far less attractive option Read more

Technology Licensing

View all
14 May 2020

Patent cliff fears drive through 2020’s second largest pharma deal

Despite an M&A slowdown amid coronavirus uncertainties, Alexion Pharmaceuticals has splashed out more than $1 billion in the face of imminent threats to its IP position in the US and Europe Read more

11 May 2020

Sisvel wins closely watched German FRAND case

A Supreme Court decision issued last week in favour of the licensing firm could make patent hold-out a far less attractive option Read more

6 May 2020

UK parliament committee warned on China’s plans for Imagination Technologies

Imagination owner explains that licensing IP is not the same as transferring it, but freshly resigned CEO claims that only diligent management oversight can prevent key trade secret loss Read more

30 Apr 2020

SEP holders are under no obligation to license to all under EU law

Why FRAND commitments do not mean that patent owners must do deals with everyone in the production chain Read more

Trade Secrets

View all
14 May 2020

Patent cliff fears drive through 2020’s second largest pharma deal

Despite an M&A slowdown amid coronavirus uncertainties, Alexion Pharmaceuticals has splashed out more than $1 billion in the face of imminent threats to its IP position in the US and Europe Read more

6 May 2020

UK parliament committee warned on China’s plans for Imagination Technologies

Imagination owner explains that licensing IP is not the same as transferring it, but freshly resigned CEO claims that only diligent management oversight can prevent key trade secret loss Read more

30 Apr 2020

IP is crucial to finding breakthrough covid-19 medicines, Novartis policy head states

“We are only in the position to tackle the pandemic, because of where the system has brought us so far,” says Corey Salsberg in an exclusive interview with IAM Read more

23 Apr 2020

AI has never been more important in the life sciences

Use of artificial intelligence and machine learning has produced an explosion in life sciences partnerships, while raising new IP questions Read more

Valuation

View all
14 May 2020

Patent cliff fears drive through 2020’s second largest pharma deal

Despite an M&A slowdown amid coronavirus uncertainties, Alexion Pharmaceuticals has splashed out more than $1 billion in the face of imminent threats to its IP position in the US and Europe Read more

2 May 2020

It’s a downturn Jim, but not as IP owners know it

Patent rights may fare well in a recession but this is a global market unlike any other we have seen before Read more

24 Apr 2020

Private equity investor buys majority stake in IP pioneer Ocean Tomo

New capital will help Chicago-based business scale-up as it looks to develop new marketplace, says firm's head Jim Malackowski; possible expansion of international arm into India and Brazil also being considered Read more

16 Apr 2020

Exclusive: New IP policy to help forge partnerships on potential UK covid-19 vaccine

Licensing deals on crucial technologies expected in next two months, says Oxford University tech transfer chief, after scientist indicates significant progress in efforts to find coronavirus treatment Read more

Find an expert

Stephen D Prowse
Senior Managing Director
Dallas TX, United States
FTI Consulting Inc